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Abstract 
Objective 
Women with overactive bladder (OAB) often undergo urodynamics before invasive 
treatments are considered. Ultrasound measurement of bladder wall thickness (BWT) is a 
less invasive, less expensive and widely available test. It has the potential to diagnose the 
presence of Detrusor Overactivity (DO). We aimed to evaluate the accuracy of BWT in 
diagnosis of DO.  
Design 
Prospective cohort study 
Setting  
22 UK clinics (university and district general hospitals)  
Methods 
Consecutive eligible women with OAB symptoms had transvaginal ultrasound to 
estimate BWT (index test). The reference standard for the diagnosis of DO was 
urodynamic testing with multichannel subtracted cystometry. 
Main outcome measures 
The sensitivity, specificity and likelihood ratios using a BWT threshold of ≥5mm to 
indicate the presence of DO, and the area under the receiver operating characteristics 
(ROC) curve to give an overall estimate of BWT accuracy.  
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Results 
Between March 2011-2013, 644/ 687 (94%) women recruited had both tests. The mean 
age was 52.7 years (standard deviation 13.9) and DO was diagnosed in 399/666 (60%) of 
women. BWT had a sensitivity of 43% (95% confidence interval (CI): 38-48%), 
specificity of 62% (95% CI: 55-68%), and likelihood ratios of 1.11 (95% CI: 0.92-1.35) 
and 0.93(95% CI: 0.82-1.06) for positive and negative tests respectively.  The area under 
the ROC curve was 0.53 (95% CI: 0.48-0.57). Extensive sensitivity analyses and 
subgroup analyses were carried out, but did not alter the interpretation.   
Conclusions 
BWT is not a good replacement test for urodynamics in women with overactive bladder. 
Keywords 
Overactive bladder; bladder wall; ultrasound; urodynamics; diagnostic accuracy 
Study Registration 
The study protocol was registered as ISRCTN:46820623. 
http://www.isrctn.com/ISRCTN46820623 
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Introduction 
Overactive bladder (OAB) is a debilitating condition that affects 12% of world 
population and increases with age.
1
  It is defined as a symptom complex of urinary 
urgency with or without incontinence, usually with increased urinary frequency, or 
nocturia, but in the absence of infection or other proven pathology.
2
  It is associated with 
a considerable economic burden from both a societal and patient perspective.
3
   
At present, invasive urodynamics is the gold standard test for assessment of OAB 
unresponsive to conservative management.
4
  It is an intimate and invasive test, with 
urinary tract infection (UTI) rates following urodynamics reported to be between 3 to 
20%.
5
  A common pathology underlying OAB is detrusor overactivity (DO), observed in 
54-58% of women with symptoms.
6
 At present, National Institute of Health and Care 
Excellence (NICE) guidance recommends treatments such as Botulinum toxin A or 
neurostimulation only in patients diagnosed with DO on urodynamics.[JPD1]
7
  
Bladder wall thickness (BWT) measured by ultrasonography has been proposed as a less 
invasive alternative to urodynamics to identify DO. A systematic review of BWT noted 
that all existing studies were small and of variable quality.
8
 The reported sensitivity 
varied between 40-84%, and specificity between 78-89%. The need for further evidence 
was identified as a priority in a NICE guideline
7
 and a Health Technology Assessment 
report.
9
 
We report results of a large prospective, multicentre test accuracy study undertaken to 
evaluate whether BWT measured by ultrasonography can accurately diagnose DO in 
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women with OAB symptoms.  The assessment of reproducibility of the test and the cost-
effectiveness analysis are reported elsewhere.
10
 
Methods 
Participants 
Consecutive women scheduled for investigation of OAB symptoms were prospectively 
approached for recruitment and consent (Web appendix Figure S1). Women were asked 
to complete a bladder diary for the three days preceding their test appointment.  
Women were eligible for inclusion if they provided written informed consent and 
satisfied all the following criteria: 1) urinary frequency of 9 voids or more in a 24-hour 
period for at least one day in a 3 day bladder diary; 2) mild to severe urgency recorded on 
at least two occasions in the bladder diary and 3) post void residual (PVR) volume <100 
ml.  
Exclusion criteria were: 1) symptoms of pure stress urinary incontinence (SUI) or stress 
predominant mixed incontinence; 2) current pregnancy or up to six weeks postpartum; 3) 
SUI surgery and/or intradetrusor Botulinum toxin A in the past six months; 4) urine 
dipstick positive for leucocytes or nitrites; 5) Greater than stage II (any compartment) on 
Pelvic organ prolapse quantification (POP-Q) system ; 6) previous urodynamics in the 
past six months; or 7) current or previous use of antimuscarinics for >6 months 
continuously. 
The clinical history of the participants was collected prior to the tests and included 
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previous treatments for bladder problems and the International Consultation on 
Incontinence Questionnaire-Overactive bladder (ICIQ-OAB) questionnaire.
11
. 
Procedures 
Both the bladder ultrasound and urodynamics were done within four weeks of each other 
by different practitioners. The practitioner undertaking the urodynamics was unaware of 
the result (blinded) of the ultrasonongraphy.  
Index test - bladder wall thickness on ultrasonography 
A standard operating procedure (SOP) for carrying out the transvaginal ultrasound was 
produced and clinicians were required to attend training provided by study team.  
The PVR was measured by the following formula: length x width x depth in cm x 0.5223 
in millilitres. The bladder wall was measured with a 7-9 MHz end-firing transvaginal 
probe in the sagittal plane introduced 1 cm beyond the vaginal introitus in the midline. 
The BWT was measured at three sites perpendicular to the luminal surface of the bladder 
(Web appendix Figure S2): the thickest part of the trigone, dome in the midline and the 
anterior wall. BWT was calculated as the mean of these 3 measurements in millimetres.   
Reference standard – Urodynamics 
For urodynamics, we developed SOP based on the Good Urodynamic Practice Guidelines 
of the International Continence Society.
12
 Women attended the clinic with a full bladder 
for the uroflowmetry in privacy. Filling cystometry was performed with the woman in 
sitting position at the rate of 100mls/minute, followed by provocation manoeuvres and 
then voiding cystometry.  
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Detrusor Overactivity was detected when involuntary detrusor contractions were seen 
during filling cystometry. These contractions (spontaneous or provoked), could be of 
variable duration and amplitude, phasic or terminal, with or without urgency and/or 
urgency incontinence. Voiding dysfunction was defined as abnormally slow (<15mls/sec) 
flow and/or incomplete micturition (PVR >100 mls). 
Quality assurance 
The lead investigator assessed the competency of local investigators by reviewing at least 
five ultrasound scans prior to allowing them to enter patients into the study. A 
reproducibility assessment done for intra and interobserver variation is reported 
elsewhere.
10
 
The quality of urodynamics was audited with anonymised traces every six months  and 
comparing them to the interpretation guidelines
2
 to ensure ongoing quality assurance.
13
  
Statistical methods 
Sample size 
A minimum target sample size of 600 participants was pre-specified in order to obtain 
estimates of sensitivities and specificities with 95% confidence intervals (CI) of width 
10% or less, anticipating sensitivity and specificity values between 70% and 95%. The 
computation was based on a prevalence of 50% for DO
4
, providing 300 women each for 
the estimate of sensitivity and specificity.  
Ultrasound bladder wall thickness and detrusor overactivity 
9 
Data analysis 
Sensitivity, specificity and predictive values were calculated using a BWT ≥5mm 
indicating presence of DO as a pre-specified cut-off based on the evidence from previous 
studies.  Likelihood ratios for categories of BWT were also pre-specified: <3mm; ≥3mm 
to <5mm and ≥5mm.  CIs were calculated using binomial exact methods. A receiver 
operating characteristic (ROC) curve
 
was constructed and the area under the curve (AUC) 
was computed (with 95% CI) to give an overall estimate of BWT accuracy across all 
thresholds. Statistical significance was tested by comparing against the uninformative 
model (i.e. where AUC=0.5) using a non-parametric approach.
14
  BWT measurements in 
groups with and without DO were compared using a two-sample t-test. The relationship 
of BWT with pre-test ICIQ-OAB score was tested using simple linear regression. 
Statistical significance was defined as p<0.05. 
Sensitivity analyses were performed on the primary population to test the robustness of 
the results to protocol deviations (excluding those where tests were not blinded or 
undertaken >4 weeks apart), missing data (incorporating measurements where not all 
three components of the BWT were available) and more stringent inclusion criteria 
(excluding those with mixed stress/urge incontinence; and excluding those with post void 
residual urine volume >30ml).  We also investigated the impact of using different BWT 
measures (trigone alone; mean of dome with measures 1cm to the left and right of the 
dome). 
The accuracy of BWT was compared between subgroups according to 1) previous 
treatment with antimuscarinics, 2) a clinical history suggesting mixed incontinence, 3) 
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presence of a UTI in the previous 12 months, 4) voiding difficulties, 5) previous 
incontinence surgery and 6) BMI (<25, ≥ 25).  ROC curves were generated for each 
subgroup and the AUC compared using a large sample chi-squared test for independent 
curves.
15
  
Exploratory analyses were undertaken to identify variables that predicted a diagnosis of 
DO using multivariable logistic regression. The variables considered were BWT 
measurement, ICIQ-OAB scores, age, duration of symptoms, ethnicity, vaginal birth, 
menopausal status, parity, previous POP surgery and the subgroups listed above. 
Results 
Participants 
Six hundred and eighty seven women who were eligible and consented to participate 
were recruited from 22 centres between March 2011 - 2013. The study over-recruited to 
compensate for study withdrawals and women without complete index and reference 
standard test results (Figure 1). 
The mean age of women was 52.7 years (standard deviation [SD]: 13.9) and the average 
BMI was 30.6 (SD: 12.2) (Table 1). Of the 687 women, 387 (55%) were postmenopausal. 
According to clinical history, 419 (61%) had urgency-predominant mixed incontinence 
and 226 (33%) reported only urinary urgency and frequency. The median duration of 
symptoms was 3.0 years (Inter Quartile Range: 1.6 to 7.0). 
Test completion 
Complete urodynamic diagnoses were obtained in 666/687(97%) of women (Figure 1). 
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Of these, 399 (60%) were diagnosed with DO (95% CI: 56-64%) (Web appendix Table 
S1) and 245 (61%) were given a further sub-diagnosis of DO incontinence (defined as 
detrusor pressure rise and leak).  
All three BWT measurements (trigone, dome midline, anterior wall midline) were 
available in 645 (94%) women. The average BWT measurement was 4.78mm (SD 1.34) 
(Web appendix Table S2). 
Of the 644 participants who had the two tests (Figure 1), both were performed on the 
same day in 439 (68%); and only 26 (4%) were performed more than four weeks apart. 
Ninety-seven percent of reference tests (616/632, twelve observations missing) were 
confirmed as being blind to the index test. No serious adverse events were reported 
following either test, although 49/479(10%) of those responding at six month follow-up 
reported having urine infection within two weeks of the test. Of these, 36/48 (one 
observation missing) were diagnosed by a General Practitioner. 
Estimates of test accuracy 
BWT showed poor sensitivity (43%; 95% CI: 38-48), specificity (62%; 95% CI: 55-68), 
positive (63%; 95% CI: 57-69) and negative (41%; 95% CI: 36-47) predictive values for 
diagnosis of DO (Table 2).  
Likelihood ratios were non-discriminatory at all pre-specified cut-offs of ≥ 5mm (1.11; 
95% CI: 0.92-1.35), ≥3mm <5mm (0.96; 95% CI: 0.83-1.13) and <3mm (0.76: 95% CI: 
0.46, 1.26) (Web appendix Table S3).   
The ROC curve (Figure 2) showed no evidence of discrimination at any threshold 
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between those with and without DO (AUC 0.53; 95% CI: 0.48- 0.57; p=0.25). There was 
no evidence that the mean BWT measurements were any higher in the DO positive group 
than in the DO negative group (mean (SD): 4.85(1.36) mm versus 4.70(1.29) mm; 
p=0.19) (Web appendix Figure S3); or that BWT had any relationship with pre-test ICIQ-
OAB symptoms score (r=-0.01; p=0.88).  The AUC remained below 0.55 in all 
sensitivity analyses and in all pre-specified subgroups (Web appendix Figures S4-S13 
and Table S4). 
In the multivariable exploration of factors possibly associated with DO diagnosis, only 
higher baseline ICIQ score (worse symptoms) was associated with DO (OR: 1.21; 95% 
CI: 1.13- 1.29; p<0.0001), i.e. the odds of DO diagnosis were increased by 21% for every 
point increase in ICIQ score (Web appendix Tables S5-S6). 
Discussion 
Summary of Main Findings 
Bladder wall ultrasonography appeared to be no better than chance at making the 
diagnosis of DO, with an AUC of 0.53 (95% CI: 0.48-0.57). Extensive sensitivity 
analyses and subgroup analyses were carried out but did not alter the interpretation of 
these findings.  Furthermore, BWT had no relationship to ICIQ score upon presentation, 
indicating that it has no relationship with symptom severity.  Based on this evidence, we 
conclude that BWT is not a useful test in diagnosing DO and should not be used in 
clinical practice. 
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Strengths and Limitations 
The BUS study is the biggest test accuracy study on the subject; it was designed to 
minimize bias and ensure that the results would be applicable to imaging services 
available in routine clinical practice. We attempted to recruit consecutive women 
fulfilling the eligibility criteria. Women were of mixed ages, ethnicities and were 
recruited from multiple centres across the UK. The prevalence of DO in our study was 
60%, which was similar to other studies.
6
 
As transvaginal bladder ultrasound is a relatively new technique, concerns may be raised 
on the quality of scan measurements. However, the technique has been easy to teach and 
learn (personal experience of the authors) with the urinary bladder being an anterior and 
relatively superficial midline structure and previously has been reported to be 
reproducible .
16
 Both ultrasonongraphy and urodynamics were undertaken in 94% of 
women, and blinding of test results ensured for 97% of them. Risk of disease progression 
bias was minimized by conducting the tests within 4 weeks of each other in 96% of 
women.  All analyses and cut-offs were pre-specified in the protocol. The study was 
powered to ensure that estimates of sensitivity and specificity would be made with 
adequate precision to draw robust conclusions, and we recruited beyond the target. We 
have undertaken multiple sensitivity analyses to investigate the impact of excluding 
women with variations in presentation such as urgency predominant mixed incontinence 
in the study, and in all cases these additional analyses have shown no discrimination.  
One area of concern is misclassification made by the reference standard.
17
 Urodynamics 
is known to be less than 100% reproducible in previous studies of patients with OAB and 
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healthy volunteers.
18
 Errors in the reference standard typically lead to underestimation of 
sensitivity and specificity but misclassification rates would have to be extreme for no 
relationship to be observed at all.  The poor accuracy for BWT elicited in our study is 
thus likely to mainly be explained by the fact that BWT bears no relation to DO. This is 
reinforced by no relationship being observed between BWT and disease severity 
measured by the ICIQ-OAB questionnaire, whereas there was a strong relationship 
between DO status from urodynamics and the ICIQ-OAB. 
Interpretation in light of other evidence 
The initial studies suggested a greater BWT to be an accurate diagnostic marker for DO. 
For a mean BWT cut-off of 5mm, the specificity was reported to be 89% (95% CI 79- 96) 
with a sensitivity of 84% (95% CI 76-90). 
16
 We identified  further studies
19-30
, which 
investigated the relationship between BWT measured by ultrasonography and DO, with 
estimates of sensitivity, specificity and AUC for bladder ultrasound varying from 37-
91%, 61-97% and 0.61-0.91 respectively.
8
  
The published studies are mostly from single centre (often tertiary) and with multiple 
reasons to have concerns about the validity and applicability of findings. Some studies 
added ambulatory urodynamics to the reference standard, if the patients had normal 
video-urodynamics, as a tie-breaker test.
16
 Some studies
19, 23-26
 made comparisons with 
healthy controls, some
28
 excluded patients with mixed urinary incontinence and one 
enriched with women with equivocal urodynamics findings.
30
 Altering the spectrum of 
patients from that encountered in practice influences the estimates of sensitivity and 
specificity
17
; exclusion of the mixed urinary incontinence cases and inclusion of healthy 
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controls will lead to overestimation of test accuracy; enrichment with difficult to 
diagnose cases will underestimate test accuracy.  Some studies used transabdominal
23, 25, 
27
 or translabial ultrasound with higher interobserver variability.
26
  
Our study focused on recruiting women with urgency or urgency predominant mixed 
incontinence undergoing urodynamics to identify DO.  Some of the previous studies that 
compare pure SUI with OAB have assessed the value of ultrasonography to differentiate 
between SUI and DO: the higher observed accuracy may well reflect that BWT is higher 
in those with DO than with SUI,
21
 but this is not of direct relevance to the clinical role 
that ultrasonography could play.  
There is some emerging evidence in literature that the response to invasive therapies 
might be similar in patients with frequency and urgency with or without incontinence, 
regardless of the observation of DO. Everything seems to be more complicated when 
there is mixed incontinence involved, and urodynamics might have value there.
10
 
Robustly designed randomized controlled trials are required to evaluate whether patients 
are more likely to benefit from decisions to use invasive therapies based on urodynamic 
findings of DO versus just clinical evaluation alone.
10
 
Conclusion 
Bladder wall thickness ultrasonography cannot identify women with Detrusor 
Overactivity and hence cannot be used to reduce the need for invasive urodynamics.    
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Legends 
Figure 1: Participant flow diagram 
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Figure 2: Receiver operating curve of transvaginal bladder wall thickness scan in the 
diagnosis 
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Table 1: Characteristics of included participants (n=687) 
Age (years) Mean (SD) 52.7 (13.9) 
Missing 0 (-) 
Ethnicity 
White British/Irish/Other  538 (78%) 
Asian Pak/Ind/Bang/other 72 (10%) 
Black Carrib/African/other 49 (7%) 
Mixed/other 18 (3%) 
Not given/missing 10 (1%) 
Parity  
0 69 (10%) 
1 90 (13%) 
2 241 (35%) 
3 152 (22%) 
4 56 (8%) 
>4 63 (9%) 
Missing 16 (2%)   
Post-menopausal (lmp>1 year) 
Yes 378 (55%) 
No 293 (43%) 
Missing 16 (2%) 
BMI (kg/m2) 
Mean (SD) 
Missing 
 
30.6 (12.2) 
28 
Incontinence type 
Mixed urinary incontinence 419 (61%) 
Urgency  incontinence alone 226 (33%) 
Stress  incontinence alone 4 (1%) 
Neither 19 (3%) 
Missing 19 (3%) 
19 (3%) 
If mixed, what started first (n=419)? 
Urgency 226 (54%) 
Stress 107 (26%) 
Unsure 54 (13 ) 
Missing 32 (8%) 
Current or previous treatment with anti-
muscarinics 
Yes 226 (33%) 
No 444 (65%) 
Missing 17 (2%) 
Recurrent cystitis (3 or more in last 12 
months) 
Yes 50 (7%) 
No 606 (88%) 
Missing 31 (5%) 
Voiding difficulties Yes 286 (42%) 
No 374 (54%) 
Missing 27 (4%) 
Vaginal birth Yes 561 (82%) 
No 95 (14%) 
Missing 31 (5%) 
Previous incontinence surgery Yes 36 (5%) 
No 623 (91%) 
Missing 28 (4%) 
Previous POP/UI surgery Yes 56 (8%) 
No 603 (88%) 
Missing 28 (4%) 
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Table 2: Accuracy of bladder wall thickness ≥5mm for diagnosis 
of Detrusor Overactivity  
 Estimate  in % 95% CI 
Sensitivity 43% (165 TPs of 388 with DO) 38 to 48% 
Specificity 62% (158 TNs of 256 without DO) 55 to 68% 
Positive predictive value 63% (165 TPs of 263 with BWT≥5mm) 57 to 69% 
Negative predictive value 41% (158 TNs of 381 BWT<5mm) 36 to 47% 
Positive likelihood ratio 1.11 0.92 to 1.35 
Negative likelihood ratio 0.93 0.82 to 1.06 
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Figure S1: Study flow chart 
Ultrasound bladder wall thickness and detrusor overactivity 
29 
Figure S2: Transvaginal scan showing measurements of the 
trigone, anterior wall and dome of the bladder 
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Figure S3: Box and whisker plot comparing bladder wall 
thickness with detrusor overactivity diagnosis 
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Figure S4: ROC curve from sensitivity analysis excluding those 
results where the urodynamics test was not blind to the results of 
the ultrasound test (16/632 women (3%);  AUC: 0.528, 95%CI: 
0.480, 0.575; p=0.25) 
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Figure S5: ROC curve from sensitivity analysis excluding those 
results where there was more than four weeks between the tests 
(26/660 women (4%); AUC: 0.526, 95%CI: 0.479, 0.572; p=0.28) 
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Figure S6: ROC curve from sensitivity analysis incorporating 
incomplete ultrasound measurements (10 observations – average 
of remaining one or two measurements used; AUC: 0.529, 
95%CI: 0.484, 0.574; p=0.21) 
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Figure S7: ROC curve from exploratory analysis including the 
urgency alone group (as per clinical history; excluding mixed 
stress/urge incontinence group: 217 patients; AUC: 0.530, 
95%CI: 0.452, 0.609; p=0.45) 
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Figure S8: ROC curve from exploratory analysis excluding those 
who had PVR>30ml upon testing (34 cases AUC: 0.526, 95%CI: 
0.479, 0.572; p=0.28) 
 
Figure S9: ROC curve from exploratory analysis using the 
trigone measurement alone for BWT (AUC: 0.519, 95%CI: 0.473, 
0.564; p=0.42) 
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Figure S10: ROC curve from exploratory analysis using the 
average dome, 1cm left of dome, 1cm right of dome (AUC: 0.537, 
95%CI: 0.491, 0.582; p=0.12) 
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Figure S11: ROC curve from exploratory analysis redefining 
those who had detrusor pressure rise upon provocation testing 
‘provoked DO’ as DO negative (187 cases; AUC: 0.541, 95%CI: 
0.487, 0.595; p=0.14) 
 
  
Ultrasound bladder wall thickness and detrusor overactivity 
39 
Figure S12: ROC curve from exploratory analysis redefining 
those with ‘mixed’ DO (DO with another diagnosis of USI or 
voiding dysfunction) as do negative; AUC: 0.489, 95%CI: 0.440, 
0.531; p=0.54) 
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Figure S13: ROC curve from exploratory analysis redefining 
those with ‘dry’ DO as DO negative; AUC: 0.548, 95%CI: 0.501, 
0.594; p=0.05) 
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Table S1: Summary of all urodynamic diagnoses 
 Number of women (%) n=666 
Diagnoses that include DO (n=399): 
DO only 258 (39%) 
DO/USI 97 (15%) 
DO/voiding dysfunction 18 (3%) 
DO/voiding dysfunction/USI 12 (2%) 
DO/low compliance 8 (1%) 
DO/USI/low compliance 5 (1%) 
DO/voiding dysfunction/USI/low compliance 1 (<1%) 
Diagnoses that do not include DO (n=267): 
Normal 124 (19%) 
USI only 78 (12%) 
Low compliance only 36 (5%) 
Voiding dysfunction only 14 (2%) 
Voiding dysfunction/USI 8 (1%) 
USI/low compliance 6 (1%) 
Voiding dysfunction/low compliance 1 (<1%) 
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Table S2: Bladder wall thickness (mm) summary statistics   
 Overall group DO positive DO negative 
Measurement Mean (SD), n Min, 
max 
Mean (SD), n Min, max Mean (SD), n Min, 
max 
Trigone 4.51 (1.49), 648 1.20, 
9.90 
4.55 (1.52), 
391 
1.20, 9.50 4.46 (1.44), 
257 
1.20, 
9.90 
Dome midline 5.01 (1.67), 653 1.30, 
11.90 
5.15 (1.68), 
394 
1.60, 
10.80 
4.79 (1.62), 
259 
1.30, 
11.90 
Anterior wall  
 
4.86 (1.52), 650 1.60, 
11.30 
4.86 (1.54), 
391 
1.60, 
11.30 
4.85 (1.50), 
259 
1.60, 
9.30 
Average of 
above 3 
4.79 (1.33), 
644 
1.80, 
9.60 
4.85 (1.36), 
388 
1.80, 9.60 4.70 (1.29), 
256 
1.97, 
9.17 
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Table S3: Likelihood ratios for bladder wall thickness for 
diagnosis of Detrusor Overactivity  
  Reference standard (Urodynamics) LR 95% CI 
  DO Non-DO Total   
Index test: 
BWT by 
ultrasound  
≥5 mm 165 98 263 1.11 0.92 to 1.35 
≥3mm<5mm 193 132 325 0.96 0.83 to 1.13 
<3 mm 30 26 56 0.76 0.46 to 1.26 
Total 388 (60%) 256 (40%) 644   
Ultrasound bladder wall thickness and detrusor overactivity 
44 
Table S4: Results of Receiver Operator Characteristics (ROC) 
curve analysis in pre-specified subgroupings 
Variable  AUC 95% CI p-value for 
difference between 
AUCs 
Previous treatment with antimuscarinics =No 0.536 (0.481, 
0.592) 
0.48 
 =Yes 0.501 (0.420, 
0.582) 
 
Clinical history suggested mixed incontinence =No 0.534 (0.460, 
0.608) 
0.73 
 =Yes 0.518 (0.460, 
0.575) 
 
Presence of Urinary Tract Infections in the 
last 12 months 
=No 0.530 (0.482, 
0.578) 
0.53 
 =Yes 0.586 (0.417, 
0.755) 
 
Patients with voiding difficulties =No 0.533 (0.472, 
0.594) 
0.84 
 =Yes 0.524 (0.454, 
0.593) 
 
Previous incontinence surgery =No 0.526 (0.479, 
0.573) 
0.76 
 =Yes 0.493 (0.294, 
0.693) 
 
BMI <25 0.519 (0.424, 
0.614) 
0.95 
 >=25 0.523 (0.471, 
0.575) 
 
AUC- area under the curve
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Table S5: Results of univariate analysis exploring factors possibly 
associated with Detrusor Overactivity (DO) diagnosis 
Variable Data type p-value OR (95%CI) if 
statistically 
important  
Frequencies 
(binary/categorical 
data) 
ICIQ score (best=0, worst=16) Continuous <0.0001 1.23 (1.15, 1.31)  
BWT, mm Continuous 0.19   
Age, years Continuous 0.66   
Duration of symptoms, years Continuous 0.45   
BMI, kg/m2 Continuous 0.38   
Ethnicity 
(white/black/Asian/other) 
Categorical 0.59   
Vaginal birth=yes Binary 0.64   
Clinical history suggests 
mixed incontinence=yes 
Binary 0.40   
If clinical history suggests 
mixed incontinence, which 
came first 
(stress/urge/unsure/na) 
Categorical 0.66   
Previous treatment with 
antimuscarinics=yes 
Binary 0.001 1.74 (1.24, 2.44) 68% (152/222) DO 
when=yes 
56% (245/441) DO 
when=no 
Previous UTI in last 12 
months=yes 
Binary 0.08 0.60 (0.34, 1.07) 48% (24/50) DO  
when=yes 
61% (363/599) DO 
when=no 
History of voiding 
difficulties=yes 
Binary 0.16   
Post-menopausal=yes Binary 0.67   
Parity (0/1/2/3/4+) Categorical 0.27   
Previous incontinence 
surgery=yes 
Binary 0.59   
Previous POP surgery=yes Binary 0.32   
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Table S6: Results of multivariable analysis exploring factors possibly 
associated with Detrusor Overactivity diagnosis 
Model Significant variables p-value OR (95%CI) if 
significant 
Backward selection (p=0.1 
to stay in model)  
ICIQ score 
Previous UTI in last 12 months 
<0.0001 
0.04 
1.21 (1.13, 1.29) 
0.51 (0.27, 0.97) 
All variables included ICIQ score 
Previous UTI in last 12 months 
<0.0001 
0.06 
1.21 (1.13, 1.29) 
0.53 (0.27, 1.03) 
All variables included, 
multiple imputation used 
for missing data 
ICIQ score 
Previous treatment with 
antimuscarinics 
Previous UTI in last 12 months 
<0.0001 
0.02 
0.07 
1.23 (1.15, 1.31) 
1.57 (1.09, 2.28) 
0.57 (0.31, 1.06) 
 
 
 
